Presentation is loading. Please wait.

Presentation is loading. Please wait.

Thrombus Obliteration by Rapid Percutaneous Endovenous Intervention in Deep Venous Occlusion “TORPEDO” trial : Mid –Term results Mohsen Sharifi,MD,FACC,

Similar presentations


Presentation on theme: "Thrombus Obliteration by Rapid Percutaneous Endovenous Intervention in Deep Venous Occlusion “TORPEDO” trial : Mid –Term results Mohsen Sharifi,MD,FACC,"— Presentation transcript:

1 Thrombus Obliteration by Rapid Percutaneous Endovenous Intervention in Deep Venous Occlusion “TORPEDO” trial : Mid –Term results Mohsen Sharifi,MD,FACC, Mahshid Mehdipour, Curt Bay, PhD, Gary Smith,MD, Jalaladdin Sharifi,MD Arizona Cardiovascular Consultants & A.T. Still University, Mesa, AZ

2 TORPEDO TRIAL First Randomized trial Evaluating Reduction of DVT Sequelae with Percutaneous Endovenous Intervention (PEVI)

3 183 Randomized Control No=92 PEVI No=91 8 pts PEVI 88 Control 81 F/U at 30±5months

4 TORPEDO TRIAL Primary endpoints Post- thrombotic Syndrome Recurrent Venous Thromboembolic Disease Secondary Endpoints Skin Induration Leg Edema Hospital Stay Subjective Perception of Improvement Bleeding

5 Conclusions PEVI + anticoagulation is superior to anticoagulation alone in: Reduction of recurrent VTE. Reduction of PTS Reduction of hospital stay Reduction of leg edema Reduction of skin induration Reduction in duration of parenteral anticoagulants Subjective perception of improvement


Download ppt "Thrombus Obliteration by Rapid Percutaneous Endovenous Intervention in Deep Venous Occlusion “TORPEDO” trial : Mid –Term results Mohsen Sharifi,MD,FACC,"

Similar presentations


Ads by Google